Ashland (ASH) Stock Overview
Provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
ASH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Ashland Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$71.83 |
| 52 Week High | US$78.25 |
| 52 Week Low | US$46.30 |
| Beta | 0.39 |
| 1 Month Change | -4.73% |
| 3 Month Change | 9.61% |
| 1 Year Change | 35.43% |
| 3 Year Change | -11.59% |
| 5 Year Change | -22.54% |
| Change since IPO | 652.77% |
Recent News & Updates
Narrative Update • Sep 03
ASH: Oral Biologics Push And Dividend Outlook Will Shape Future Returns
Analysts have lifted their fair value estimate for Ashland from $51.07 to $70.00, citing updated assumptions on the discount rate, profit margin, revenue growth, and a higher future P/E multiple. What’s in the News for Ashland Ashland launched permexa sodium caprate, an intestinal permeation enhancer aimed at oral peptide and biologic drugs, including GLP 1 agonists, with strong pre launch engagement and positive feedback from pharmaceutical, biotech and CDMO customers.Seeking Alpha • Aug 13
Ashland Inc.: Activist Pressure Starts To Pay Off
Summary Ashland Inc. (ASH) remains a Buy, with the investment case now centered on activist-driven M&A potential and strategic alternatives. Life Sciences and Personal Care segments, comprising 82% of gross EBITDA, continue to deliver growth and margin stability, underpinning valuation. Multiple activist investors, including Standard Industries and Ancora, have driven board changes, capital allocation reviews, and engagement with potential acquirers. With shares up from $57.46 to ~$75, further upside hinges on a bull-case M&A scenario, with a high $80s takeout plausible and downside limited by ongoing activist pressure. Read the full article on Seeking Alpha
Narrative Update • Aug 13
ASH: Activist Engagement And Q2 Execution Will Shape Fairly Valued Shares
Analysts have lifted their price target for Ashland from about $73.64 to roughly $80.18, reflecting updated assumptions around revenue growth, profit margins, discount rate and the P/E multiple they apply to future earnings. What’s in the News for Ashland Ashland reported second quarter earnings that were ahead of analyst expectations on both earnings per share and sales, and the company kept its full year 2026 sales guidance in place.Recent updates
Narrative Update • Sep 03
ASH: Oral Biologics Push And Dividend Outlook Will Shape Future Returns
Analysts have lifted their fair value estimate for Ashland from $51.07 to $70.00, citing updated assumptions on the discount rate, profit margin, revenue growth, and a higher future P/E multiple. What’s in the News for Ashland Ashland launched permexa sodium caprate, an intestinal permeation enhancer aimed at oral peptide and biologic drugs, including GLP 1 agonists, with strong pre launch engagement and positive feedback from pharmaceutical, biotech and CDMO customers.Seeking Alpha • Aug 13
Ashland Inc.: Activist Pressure Starts To Pay Off
Summary Ashland Inc. (ASH) remains a Buy, with the investment case now centered on activist-driven M&A potential and strategic alternatives. Life Sciences and Personal Care segments, comprising 82% of gross EBITDA, continue to deliver growth and margin stability, underpinning valuation. Multiple activist investors, including Standard Industries and Ancora, have driven board changes, capital allocation reviews, and engagement with potential acquirers. With shares up from $57.46 to ~$75, further upside hinges on a bull-case M&A scenario, with a high $80s takeout plausible and downside limited by ongoing activist pressure. Read the full article on Seeking AlphaNarrative Update • Aug 13
ASH: Activist Engagement And Q2 Execution Will Shape Fairly Valued Shares
Analysts have lifted their price target for Ashland from about $73.64 to roughly $80.18, reflecting updated assumptions around revenue growth, profit margins, discount rate and the P/E multiple they apply to future earnings. What’s in the News for Ashland Ashland reported second quarter earnings that were ahead of analyst expectations on both earnings per share and sales, and the company kept its full year 2026 sales guidance in place.Narrative Update • Jul 30
ASH: Activist Engagement And Steady Execution Will Shape Fairly Valued Shares
Analysts have modestly lifted their price target for Ashland to $73.64 from $70.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E multiples. What’s in the News for Ashland Ashland reported third quarter fiscal 2026 results with sales up 7% year over year and growth across all business units and regions.Narrative Update • Jul 16
ASH: Index Shifts And Activist Pressure Will Guide Fairly Valued Shares
Analysts have adjusted their price target on Ashland to $70.00, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margin, and a slightly higher future P/E multiple. What’s in the News for Ashland Ashland Inc.
Narrative Update • Jul 01
ASH: Activist Sale Pressure And Cash Returns Will Drive Future Upside
The analyst fair value estimate for Ashland has been adjusted from $75.00 to about $89.70, with analysts pointing to updated assumptions for revenue growth, profit margins, and future P/E as key drivers of the change. What’s in the News for Ashland Ashland Inc.Analysis Article • Jun 20
Ashland (ASH) Stock Could Be 26.4% Below Fair Value After Recent Rally
Ashland (ASH) has drawn attention after recent share price gains over the past month and past 3 months, prompting investors to reassess how its specialty chemicals mix and current valuation metrics align with its fundamentals. See our latest analysis for Ashland. At a share price of $67.92, Ashland has seen strong recent momentum, with a 30 day share price return of 20.73% and a 1 year total shareholder return of 43.33%, contrasting with weaker 3 and 5 year total shareholder returns. If...Narrative Update • Jun 17
ASH: Activist Pressure And Operational Setbacks Will Shape Shares And Capital Returns
The Ashland analyst price target has been adjusted slightly from $67.10 to about $67.27 as analysts update their assumptions around discount rates, revenue growth, profit margins, and the future P/E they apply to the stock. What’s in the News for Ashland Activist investor Ancora Alternatives has built a significant stake in Ashland and is urging the board to review options including a potential sale of the company.Narrative Update • Jun 03
ASH: Guidance Reset And Free Cash Flow Focus Will Drive Future Upside
Analysts have raised their price target on Ashland from $73.00 to $75.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a future P/E of 16.59x. What's in the News Ashland reported Q2 2026 earnings and sales that came in weaker than expected, with management pointing to operational issues at the Hopewell manufacturing facility, softness in the Intermediates segment, weaker pricing, and reduced energy related demand as key pressures.Narrative Update • May 15
ASH: Dividend And Guidance Updates Will Shape Margins And Future Returns
Analysts now see Ashland's fair value at about $51.07, down from $60.00, as they reset assumptions around profit margin and future P/E while keeping revenue growth expectations broadly steady. What's in the News Ashland's board declared a quarterly cash dividend of $0.42 per share on common stock, a 1.2% increase from the previous quarter, payable June 15, 2026, to shareholders of record on June 1, 2026 (company announcement).Narrative Update • May 01
ASH: Future Margins Will Likely Improve On 2026 Guidance And Completed Buybacks
Analysts keep their average Ashland price target steady at $60.00, citing small model tweaks such as a slightly lower discount rate, modestly higher revenue growth and profit margin expectations, and a marginally lower future P/E assumption as the basis for this unchanged view. What's in the News Ashland updated full-year fiscal 2026 sales guidance to a range of $1,835 million to $1,870 million, giving you a specific revenue band to track for the upcoming year (Key Developments).Narrative Update • Apr 16
ASH: EMEA Partnership And 2026 Guidance Will Support Future Upside
Analysts have maintained their $73.00 price target for Ashland, citing revised assumptions for discount rates, revenue growth, profit margins, and a lower future P/E estimate as the main factors supporting the unchanged outlook. What's in the News Ashland reported that from October 1, 2025 to December 31, 2025, it did not repurchase any shares under its existing program.Narrative Update • Apr 02
ASH: EMEA Distribution Partnership And Buybacks Will Support Future Upside Potential
Analysts have held Ashland's fair value at $73.00, with updated assumptions that include a slightly higher discount rate, a modest adjustment to revenue growth, a lower profit margin outlook, and a higher future P/E. Together these factors shape the latest view on the stock's risk and return trade off.Narrative Update • Mar 19
ASH: Future Margins Will Likely Improve On Expanded EMEA Distribution And Buybacks
Analysts have adjusted their price target on Ashland from $51.00 to $60.00. This reflects updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Narrative Update • Mar 04
ASH: Global Distribution Partnership Will Support Future Upside Potential
Analysts have trimmed their price target on Ashland to $73 from $77, reflecting updated assumptions that include slightly different revenue growth and discount rate inputs, along with a higher projected profit margin and a lower future P/E multiple. What's in the News Ashland reported that between October 1, 2025 and December 31, 2025, it repurchased 0 shares under its existing buyback, while confirming that the overall program launched on June 28, 2023 has reached 5,826,514 shares, or 11.86%, for a total of $480.07 million (Key Developments).Narrative Update • Feb 18
ASH: Repurchases And New Distribution Partnership Will Support Stronger Future Performance
Analysts have lifted their price target on Ashland from $63.20 to $67.10, reflecting updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E estimate. What’s in the News Ashland completed a share repurchase program covering 5,826,514 shares, representing 11.86% of the company, for a total of $480.07m under the buyback announced on June 28, 2023 (Key Developments).Analysis Article • Feb 06
Ashland (NYSE:ASH) Is Paying Out A Dividend Of $0.415
Ashland Inc. ( NYSE:ASH ) has announced that it will pay a dividend of $0.415 per share on the 15th of March. The...Narrative Update • Feb 04
ASH: Global Distribution And Buybacks Will Support Future Upside Potential
Analysts have maintained their fair value estimate for Ashland at $77.00. They indicate that updated assumptions for revenue growth, profit margins and future P/E broadly offset one another, resulting in a stable target.Analysis Article • Jan 23
Ashland (NYSE:ASH) Will Pay A Dividend Of $0.415
The board of Ashland Inc. ( NYSE:ASH ) has announced that it will pay a dividend on the 15th of March, with investors...Narrative Update • Jan 20
ASH: Higher Margins And Buyback Support Will Drive Bullish Upside
Analysts have nudged their price target on Ashland to US$77.00, reflecting modestly higher assumed revenue growth and profit margins, alongside a slightly lower future P/E multiple in their models. What's in the News Ashland reported that from July 1, 2025 to September 30, 2025, it repurchased 0 shares for US$0 under its ongoing buyback program.Narrative Update • Jan 06
ASH: Earnings Outlook And Higher P/E Will Support Bullish Upside
Ashland's analyst price target moved from $79.00 to $77.00 as analysts factor in updated assumptions around fair value, profitability, revenue growth, and a higher future P/E multiple. What's in the News Ashland issued earnings guidance for full fiscal year 2026, giving you a clearer sense of management's current expectations for the business.Narrative Update • Dec 14
ASH: Future Margins Will Likely Deteriorate Despite Stronger Revenue Outlook
Analysts have trimmed their price target on Ashland by approximately $2.00 to reflect expectations for stronger top line growth, but meaningfully lower profit margins that together warrant a higher future earnings multiple. What's in the News Ashland issued full fiscal 2026 guidance, projecting sales of $1,835 million to $1,905 million, implying organic growth of approximately one to five percent over the prior year (company guidance).Narrative Update • Nov 28
ASH: New Guidance And Minimal Impact From Outage Will Drive Stronger Performance
Analysts have raised Ashland's fair value price target slightly from $62.40 to $63.20, citing updated expectations for revenue growth and evolving profitability assumptions. What's in the News Ashland Inc.Narrative Update • Nov 03
ASH: Operational Recovery Will Drive Future Gains Despite Temporary Plant Impact
Analysts have revised Ashland's fair value estimate downward from $64.70 to $62.40. This revision reflects updated expectations for slightly increased revenue growth but lower profit margins, which together contribute to a modestly higher projected discount rate and future P/E multiple.Analysis Article • Jul 08
Pinning Down Ashland Inc.'s (NYSE:ASH) P/S Is Difficult Right Now
It's not a stretch to say that Ashland Inc.'s ( NYSE:ASH ) price-to-sales (or "P/S") ratio of 1.2x seems quite...Analysis Article • May 17
Ashland's (NYSE:ASH) Shareholders Will Receive A Bigger Dividend Than Last Year
The board of Ashland Inc. ( NYSE:ASH ) has announced that it will be increasing its dividend by 2.5% on the 15th of...Analysis Article • Mar 29
Is There An Opportunity With Ashland Inc.'s (NYSE:ASH) 46% Undervaluation?
Key Insights Ashland's estimated fair value is US$108 based on 2 Stage Free Cash Flow to Equity Current share price of...Seeking Alpha • Feb 27
Ashland Presents Attractive Upside Emerging From The Downcycle
Summary Ashland is generating attractive free cash flow and is well-positioned to achieve its 2027 target of $600 million EBITDA and 50% FCF conversion rate. Despite the stock selling off over the last 8 months, Ashland's strategic acquisitions and divestitures have strengthened its market position, with a focus on high-margin, patent-protected products. Ashland's strong balance sheet, low leverage, and fixed-rate debt provide stability and flexibility to navigate the current downcycle in the specialty chemicals sector. With significant insider buying and undervaluation relative to peers, Ashland presents an attractive investment opportunity with potential for 17.1%-23.5% annualized returns. Read the full article on Seeking AlphaAnalysis Article • Feb 20
We Like These Underlying Return On Capital Trends At Ashland (NYSE:ASH)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Analysis Article • Feb 05
Ashland (NYSE:ASH) Takes On Some Risk With Its Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Jan 14
Here's Why Shareholders May Want To Be Cautious With Increasing Ashland Inc.'s (NYSE:ASH) CEO Pay Packet
Key Insights Ashland will host its Annual General Meeting on 21st of January CEO Guillermo Novo's total compensation...Shareholder Returns
| ASH | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -3.2% | -1.8% | 0.9% |
| 1Y | 35.4% | 4.7% | 15.5% |
Return vs Industry: ASH exceeded the US Chemicals industry which returned 4.7% over the past year.
Return vs Market: ASH exceeded the US Market which returned 15.5% over the past year.
Price Volatility
| ASH volatility | |
|---|---|
| ASH Average Weekly Movement | 4.6% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ASH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ASH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1924 | 2,900 | Guillermo Novo | www.ashland.com |
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals.
Ashland Inc. Fundamentals Summary
| ASH fundamental statistics | |
|---|---|
| Market cap | US$3.33b |
| Earnings (TTM) | US$75.00m |
| Revenue (TTM) | US$1.84b |
43.9x
P/E Ratio1.8x
P/S RatioIs ASH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASH income statement (TTM) | |
|---|---|
| Revenue | US$1.84b |
| Cost of Revenue | US$1.23b |
| Gross Profit | US$615.00m |
| Other Expenses | US$540.00m |
| Earnings | US$75.00m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.64 |
| Gross Margin | 33.39% |
| Net Profit Margin | 4.07% |
| Debt/Equity Ratio | 73.5% |
How did ASH perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield100%
Payout RatioDoes ASH pay a reliable dividends?
See ASH dividend history and benchmarks| Ashland dividend dates | |
|---|---|
| Ex Dividend Date | Sep 01 2026 |
| Dividend Pay Date | Sep 15 2026 |
| Days until Ex dividend | 9 days |
| Days until Dividend pay date | 5 days |
Does ASH pay a reliable dividends?
See ASH dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/09 21:58 |
| End of Day Share Price | 2026/09/09 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ashland Inc. is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Selesky | Argus Research Company |
| John McNulty | BMO Capital Markets Equity Research |
| David Begleiter | Deutsche Bank |